Preprocedural High-Sensitivity C-Reactive Protein Predicts Long-Term Outcome of Percutaneous Coronary Intervention

DOI Web Site Web Site PubMed 被引用文献8件 参考文献29件 オープンアクセス
  • Wada Hideki
    Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine
  • Dohi Tomotaka
    Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine
  • Miyauchi Katsumi
    Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine
  • Shitara Jun
    Department of Cardiology, Juntendo University Shizuoka Hospital
  • Endo Hirohisa
    Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine
  • Doi Shinichiro
    Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine
  • Naito Ryo
    Department of Cardiovascular Medicine, Juntendo University Urayasu Hospital
  • Konishi Hirokazu
    Department of Cardiology, Juntendo University Shizuoka Hospital
  • Tsuboi Shuta
    Department of Cardiology, Juntendo University Shizuoka Hospital
  • Ogita Manabu
    Department of Cardiology, Juntendo University Shizuoka Hospital
  • Kasai Takatoshi
    Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine
  • Hassan Ahmed
    Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine
  • Okazaki Shinya
    Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine
  • Isoda Kikuo
    Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine
  • Shimada Kazunori
    Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine
  • Suwa Satoru
    Department of Cardiology, Juntendo University Shizuoka Hospital
  • Daida Hiroyuki
    Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine

この論文をさがす

説明

<p>Background:High-sensitivity C-reactive protein (hs-CRP) has been used to predict the risk of adverse cardiac events in patients with coronary artery disease (CAD) after percutaneous coronary intervention (PCI). Less is known, however, about the association between hs-CRP and long-term outcome after PCI in the Japanese population.</p><p>Methods and Results:We studied 3,039 all-comer patients with CAD who underwent their first PCI and had data available for preprocedural hs-CRP at Juntendo University between 2000 and 2011. Patients were assigned to tertiles based on preprocedural hs-CRP concentration. We evaluated the incidence of major adverse cardiac events (MACE) including all-cause death, acute coronary syndrome (ACS), and target vessel revascularization (TVR). Patients with higher hs-CRP had a higher prevalence of current smoking, chronic kidney disease and ACS, and a lower prevalence of statin use. During a median follow-up period of 6.5 years, ongoing divergence in MACE with hs-CRP tertile was noted on Kaplan-Meier curves (hs-CRP <0.08 mg/L, 26.4%; 0.08–0.25 mg/L, 38.2%; >0.25 mg/L, 45.6%; log-rank P<0.001). After adjustment for established cardiovascular risk factors, hs-CRP was associated with higher incidence of MACE (hazard ratio [HR], 1.10; 95% CI: 1.04–1.16, P<0.001) and higher all-cause mortality (HR, 1.14; 95% CI: 1.06–1.22, P<0.001).</p><p>Conclusions:Preprocedural hs-CRP measurement is clinically useful for long-term risk assessment in Japanese patients with established CAD and undergoing PCI.</p>

収録刊行物

  • Circulation Journal

    Circulation Journal 81 (1), 90-95, 2017

    一般社団法人 日本循環器学会

被引用文献 (8)*注記

もっと見る

参考文献 (29)*注記

もっと見る

関連プロジェクト

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ